COVID - 19 Vaccination Update - Day 480 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 10 MAY 2022 8:30PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 190.65 Crore (1,90,65,51,885) today. More than 12 lakh (12,95,705) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10405912
	2^nd Dose	10026104
	Precaution Dose	4963198
FLWs	1^st Dose	18417153
	2^nd Dose	17558647
	Precaution Dose	8024258
Age Group 12-14 years	1^st Dose	30880463
	2^nd Dose	10619800
Age Group 15-18 years	1^st Dose	58807044
	2^nd Dose	43426174
Age Group 18-44 years	1^st Dose	556351829
	2^nd Dose	482874579
	Precaution Dose	317035
Age Group 45-59 years	1^st Dose	203079287
	2^nd Dose	189183809
	Precaution Dose	861126
Over 60 years	1^st Dose	126979565
	2^nd Dose	117901681
	Precaution Dose	15874221
Cumulative 1^st dose administered		1004921253
Cumulative 2^nd dose administered		871590794
Precaution Dose		30039838
Total		1906551885

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 10^th April, 2022 (480^th Day)
HCWs	1^st Dose	31
	2^nd Dose	496
	Precaution Dose	12023
FLWs	1^st Dose	105
	2^nd Dose	1219
	Precaution Dose	31741
Age Group 12-14 years	1^st Dose	161938
	2^nd Dose	339850
Age Group 15-18 years	1^st Dose	28159
	2^nd Dose	87598
Age Group 18-44 years	1^st Dose	36305
	2^nd Dose	330081
	Precaution Dose	13805
Age Group 45-59 years	1^st Dose	8535
	2^nd Dose	78147
	Precaution Dose	24671
Over 60 years	1^st Dose	5242
	2^nd Dose	51296
	Precaution Dose	84463
Cumulative 1^st dose administered		240315
Cumulative 2^nd dose administered		888687
Precaution Dose		166703
Total		1295705

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.